NextPoint Therapeutics
PrivateLast Round
Series B
Extension
Feb 14, 2024
Total Funding Raised
$196M
Company Overview
NextPoint Therapeutics is a biotechnology company developing precision immuno-oncology therapeutics that target the B7-H7/HHLA2 immune checkpoint axis to treat solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NextPoint Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
NextPoint Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Feb 14, 2024 | ||||
| Series B | Jan 10, 2023 | ||||
| Series A | Aug 13, 2020 |
Key People
Founding team and executive leadership
NextPoint Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MPM Capital | VC Round |
| Sixty Degree Capital | Series B Extension, Series B |
| Binney Street Capital | Series A, VC Round, Series B Extension, Series B |
| MPM BioImpact | Series B, Series A, Series B Extension |
| Catalio Capital Management | Series B, Series B Extension |
| Invus Opportunities | Series B Extension, Series B |
| Arkin Bio Capital | Series B Extension, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 7, 2025
Presenting preclinical data at the AACR Annual Meeting 2025.
- Apr 7, 2025
Pioneering preclinical data on NPX125 to be presented.
NextPoint Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about NextPoint Therapeutics's valuation, stock price, and market status.